SCHEMBL1984348

SCHEMBL1984348

O=C(OBr)c1cc([N+](=O)[O-])ccc1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.52
RAB9A P51151 1/20 0.52
MYC P01106 1/20 0.52
MAX P61244 1/20 0.52
PTGDR2 Q9Y5Y4 1/20 0.51
PTGS2 P35354 2/20 0.47
ELANE P08246 1/20 0.45
LMNA P02545 3/20 0.45
CTSV O60911 1/20 0.45
CTSL P07711 1/20 0.45
MAPT P10636 6/20 0.44
MAPK1 P28482 2/20 0.44
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HTT P42858 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15229768 0.86 MYC (0.55) POLBRAB9AMYCMAXPTGDR2
SCHEMBL6641665 0.83 MYC (0.66) POLBRAB9AMYCMAXPTGDR2
SCHEMBL7083803 0.81 POLB (0.56) POLBRAB9AMYCMAXPTGDR2
SCHEMBL6536346 0.75 MYC (0.56) POLBRAB9AMYCMAXCTSV
SCHEMBL1989351 0.75 SLC6A3 (0.56) POLBMYCMAXLMNAMAPT
SCHEMBL8382506 0.75 POLB (0.64) POLBRAB9AMYCMAXPTGDR2
SCHEMBL28207049 0.74 PTGS2 (0.73) POLBRAB9AMYCMAXPTGDR2
SCHEMBL6391559 0.74 PTGS2 (0.69) POLBRAB9AMYCMAXPTGDR2
SCHEMBL27607146 0.74 BCAT2 (0.57) POLBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL30338973 0.74 PTGDR2 (0.54) POLBRAB9AMYCMAXPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2337784-A1 MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2011-06-29 EP disclosed
WO-2010036871-A1 MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-04-01 WO disclosed